Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
3,91 USD | -2,98% | +27,36% | +147,47% |
Vakgebied
Aantal werknemers: 69
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Novel Bispecific Antibodies
100,0
%
| 20 | 100,0 % | 7 | 100,0 % | -64,09% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Netherlands
100,0
%
| 20 | 100,0 % | 7 | 100,0 % | -64,09% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 56 | 01-06-19 | |
Fred M. Powell
DFI | Director of Finance/CFO | 63 | 01-11-22 |
Chief Tech/Sci/R&D Officer | - | 09-11-21 | |
Chief Tech/Sci/R&D Officer | 50 | 01-01-17 | |
Chief Tech/Sci/R&D Officer | 59 | 06-02-23 | |
Chief Tech/Sci/R&D Officer | 60 | 01-05-18 | |
Robin Hume
LAW | General Counsel | - | 15-05-23 |
Human Resources Officer | - | 09-11-21 | |
Amy Garabedian
LAW | General Counsel | - | 27-07-21 |
Peter Ros
PRN | Corporate Officer/Principal | 52 | 01-01-20 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 56 | 01-06-19 | |
Karen Wilson
BRD | Director/Board Member | 61 | 01-04-21 |
James Noble
BRD | Director/Board Member | 65 | 15-06-22 |
Peter Kiener
BRD | Director/Board Member | 72 | 01-01-23 |
Jay Backstrom
BRD | Director/Board Member | 69 | 15-06-22 |
Kapil Dhingra
CHM | Chairman | 64 | 22-02-21 |
Mary Wadlinger
BRD | Director/Board Member | 64 | 01-01-23 |
Christy Oliger
BRD | Director/Board Member | 54 | 09-03-23 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 26 289 087 | 18 775 312 ( 71,42 %) | 0 | 71,42 % |
Bedrijfsgegevens
Sector
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+147,47% | 103 mln. | |
+9,16% | 45,97 mld. | |
+53,46% | 43,93 mld. | |
+11,20% | 42,34 mld. | |
-8,59% | 28,27 mld. | |
+16,40% | 27,18 mld. | |
-19,34% | 19,44 mld. | |
+13,95% | 13,83 mld. | |
+31,56% | 12,4 mld. | |
+10,63% | 11,45 mld. |
- Beurs
- Aandelen
- Aandeel LAVA Therapeutics N.V. - Nasdaq
- Onderneming LAVA Therapeutics N.V.